Targeting key proximal drivers of type 2 inflammation in disease
The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Abstract
Systemic type 2 inflammation encompassing T helper 2 (TH2)-type responses is emerging as a unifying feature of both classically defined allergic diseases, such as asthma, and a range of other inflammatory diseases. Rather than reducing inflammation with broad-acting immunosuppressants or narrowly targeting downstream products of the TH2 pathway, such as immunoglobulin E (IgE), efforts to target the key proximal type 2 cytokines - interleukin-4 (IL-4), IL-5 and IL-13 - represent a promising strategy to achieve therapeutic benefit across multiple diseases. After several initial disappointing clinical results with therapies targeting IL-4, IL-5 or IL-13 in asthma, applying a personalized approach achieved therapeutic benefit in an asthma subtype exhibiting an 'allergic' phenotype. More recently, efficacy was extended into a broad population of people with asthma. This argues that the Type 2 inflammation is broadly relevant across the severe asthma population if the key upstream drivers are properly blocked. Moreover, the simultaneous inhibition of IL-4 and IL-13 has shown significant clinical activity in diseases that are often co-morbid with asthma - atopic dermatitis and chronic sinusitis with nasal polyps - supporting the hypothesis that targeting a central 'driver pathway' could benefit multiple allergic diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lebrikizumab does not affect the binding of IL-13 to the IL-13Rα2 receptor chain, the biological role of which remains unclear81.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [81]
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69283-0 · Cited by 4,223
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Development and validation of a questionnaire to measure asthma control
Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,273
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Research works printed but not linked: 5
- Pawankar, R., Canonica, G., Holgate, S. & Lockey, R. WAO White Book on Allergy 2011–2012: Executive Summary (World Allergy Organization, 2011).
- Wenzel, S. E. et al. Inhaled pitrakinra, an IL-4/IL-13 antagonist, reduced exacerbations in patients with eosinophilic asthma. Eur. Respir. J. 36 (Suppl. 54), 713s (2010).
- Wenzel, S. et al. Dupilumab improves lung function and reduces severe exacerbations in uncontrolled asthmatics with baseline eosinophil levels above and below 300 cells/μl. Am. J. Respir. Crit. Care Med. 191, A3632 (2015).
- Kaiser, J. Medical Officer's Efficacy Review, Genentech, Omalizumab BLA STN 103976/0. US Food and Drug Administration [online] , (2003).
- Groves, R., Wilbrahams, D., Fuller, R. & Longphre, M. Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic eczema. J. Invest. Dermatol. 127 (Suppl. 1s), S54 (2007).
Cited by
Items 501–600 of 800
Wang, Y.-C., Yu, Y.-C., Chen, S., Lee, J.-C., Wang, T.-C., Lin, H.-J., Lin, C., Yao, C., Chen, T.-L., Tsai, F., et al. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.12.014 · Cited by 4
GZMA silencing inhibits JAK2/STAT1 pathway and improves allergic rhinitis
Li, L., Zhang, Y., Wang, J., Zhang, L., Gao, Y., Ji, X., Wang, T., & Zhao, F. (2025) · General Physiology and Biophysics · doi:10.4149/gpb_2024045 · Cited by 4
Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment
Gelardi, M., Barbara, F., Covelli, I., Damiani, M., Plantone, F., Notarnicola, A., Moretti, B., Quaranta, N. A. A., & Ciprandi, G. (2018) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-018-1466-5 · Cited by 4
NEW OPPORTUNITIES IN ACHIEVEMENT CONTROL OVER THE COURSE OF SEVERE BRONCHIAL ASTHMA
Ovsyannikov, N. V., Анатольевна, Б. О., ZINCHENKO, L. M., & Kozlova, E. A. (2019) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2019.12(4).63-68 · Cited by 4
Wang, L., Zhan, M., Wang, J., Chen, D., Zhao, N., Wang, L., Wang, W., Zhang, X., Huang, Y., Zhang, H., et al. (2021) · American Journal of Rhinology and Allergy · doi:10.1177/1945892421993034 · Cited by 4
Irreversible Bilateral Cicatricial Keratoconjunctivitis after Dupilumab Therapy
Nguyen, M. T., Tsukikawa, M., Lomazow, W., & Lee, M. D. (2022) · Case Reports in Ophthalmology · doi:10.1159/000525738 · Cited by 4
Polypose nasosinusienne. Rhinosinusite chronique avec polypes
Bonfils, P., Halimi, P., Gaultier, A.-L., & Lisan, Q. (2016) · Cited by 5
Mima, Y., Tsutsumi, E., Ohtsuka, T., Ebato, I., Nakata, Y., Kubota, T., & Norimatsu, Y. (2024) · Diagnostics · doi:10.3390/diagnostics14121272 · Cited by 3
Kwon, B. J., Cho, N. H., Ahn, T., Kim, G., Diệu, N. T. X., Kim, W. T., Cho, H., Seo, D. H., & Kim, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-65524-0 · Cited by 3
Xia, Z., Zhao, X., Wang, L., Huang, L., Yang, Y., Yin, X., He, L., Aga, Y., Kahaer, A., Yang, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010165 · Cited by 3
Chen, Q., Yang, T., Cheng, J., & Zhao, Q. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04004-5 · Cited by 3
Myers, E. J., Aamodt, S. E., Huecksteadt, T. P., Paine, R., Mir-Kasimov, M., Reilly, C. A., Callahan, S. J., Sanders, K. A., & Warren, K. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1555228 · Cited by 3
Wang, Z., Lu, X., Wu, L., Jiang, X., Wang, W., & Wang, Y. (2025) · Theranostics · doi:10.7150/thno.114152 · Cited by 3
Mappin‐Kasirer, B., & Pavord, I. D. (2025) · BioDrugs · doi:10.1007/s40259-025-00744-y · Cited by 5
Shakya, A., Liu, Q., Lai, C., Baker, S., Greene, S., Erdman, P. E., Rathnayake, A. D., Schoolmeesters, A., Blair, C. M., Kyurkchieva, E., et al. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100329 · Cited by 5
Sawashita, J., Honda, S., Tominaga, Y., Tomatsu, N., Espadaler, J., & Ueda, T. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70617 · Cited by 3
Biologic Therapies in Severe Asthma: Current Landscape, Clinical Evidence, and Future Directions
Okuducu, Y. K., & Kinane, T. B. (2025) · Current Pediatrics Reports · doi:10.1007/s40124-025-00373-7 · Cited by 3
Exploring the Impact of Nutrition on Atopic Dermatitis: A Review
Pan, J., & Liu, L. (2026) · Dermatologic Therapy · doi:10.1155/dth/5683408 · Cited by 3
Win Ratio Analysis to Clarify Clinical Benefits
Ramakrishnan, S., Petousi, N., Bon, J. M., Pavord, I. D., Bhatt, S. P., Rabe, K. F., Deng, W., Xia, C., Heble, J., SOLIMAN, M., et al. (2026) · CHEST Journal · doi:10.1016/j.chest.2026.02.005 · Cited by 4
Zhang, Q. X., Hu, C., Chen, Y., Chen, Y. L., Guo, C., Liu, Z., & Ding, W. (2026) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70704 · Cited by 3
Primary atopic disorders: Monogenic insights into immunity
Modi, B. P., McDonald, C., Golding, L., da Silva, L. B. R., Biggs, C. M., Körholz, J., James, E. L., & Turvey, S. E. (2026) · Journal of Human Immunity · doi:10.70962/jhi.20260006 · Cited by 3
Hamilton, J. D., Ferreira, M. A. R., Lim, W. K., Sidore, C., Wipperman, M. F., Ge, W., Song, X., Xia, C., Horowitz, J. E., Hooper, A. T., et al. (2026) · Allergy · doi:10.1111/all.70380 · Cited by 5
Self-citationT2 asthma and T2-associated diseases: a consolidated approach to biological therapy
Nenasheva, N. M. (2020) · Russian Journal of Allergy · doi:10.36691/rja1390 · Cited by 3
Dupilumab en el tratamiento del asma
Oropeza, S. A., González-Uribe, V., Del-Rio-Navarro, B. E., García-González, A. D. C., Navarrete-Rodriguez, E. M., & Valencia, A. (2021) · Revista Alergia México · doi:10.29262/ram.v67i7.779 · Cited by 3
Li, N., Shakib, S., Qian, W., Yao, X., Li, P., Nip, T. K., Bai, X., & Shen, K. (2024) · Clinical and Translational Science · doi:10.1111/cts.13763 · Cited by 3
Challenges and Opportunities in Achieving Asthma Remission
Cojocaru, E., Arcana, R. I., Radu, S., Trofor, A. C., & Cojocaru, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082835 · Cited by 4
Arthritis‐Related Adverse Reactions of Dupilumab in Treatment of Chronic Rhinosinusitis
Annadata, V., Huynh, P. P., & Liang, J. Z. (2025) · The Laryngoscope · doi:10.1002/lary.32439 · Cited by 3
Huang, S., Zeng, R., Wang, J., Qiao, X., Li, S., Zhang, D., Xu, J., & Dong, L. (2021) · Inflammation · doi:10.1007/s10753-021-01594-w · Cited by 4
Chronic Non-Healing Ulcers Associated with Atopic Inflammation: A Case Report
Yang, X., Wang, H., Song, Z., & Chen, Q. (2022) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s374964 · Cited by 3
Microbioma cutâneo e dermatite atópica
Abreu, D. B., Silva, D., Moreira, A. M., Lopes, C., & Unidade de Imunoalergologia, U. L. D. S. (2022) · Revista Portuguesa de Imunoalergologia · doi:10.32932/rpia.2022.09.086 · Cited by 9
Евгеньевич, К. П., & Arsenyeva, A. A. (2023) · Vestnik dermatologii i venerologii · doi:10.25208/vdv1384 · Cited by 3
Kang, K. M., Han, J.-H., Kim, K. S., Kim, E., Shin, Y., Park, J. H., Kim, H. C., Kim, N. Y., Kim, Y. G., Kim, H., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109852 · Cited by 3
Sha, J., Zhang, M., Feng, J., Shi, T., Li, N., & Jie, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111670 · Cited by 3
Zhou, Y., Zhou, Y., Zhang, S., Yu, S., Li, Z., Zhou, Y., Wu, Y., Zhao, Z., Zhang, H., & Li, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-73244-8 · Cited by 4
Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
Toumpanakis, D., Bartziokas, Κ., Bakakos, A., Fouka, E., Bakakos, P., Loukides, S., Steiropoulos, P., & Papaioannou, A. Ι. (2025) · Pulmonary Therapy · doi:10.1007/s41030-025-00291-5 · Cited by 5
Role of moisturizers and cleansers in managing pediatric eczema
Gupta, P., & Sangwan, P. (2025) · Indian Journal of Skin Allergy · doi:10.25259/ijsa_36_2025 · Cited by 3
Gahramanova, M., Халилова, Ю. И., Omarov, A. A., Susak, Y. M., Rudyk, M. P., & Skivka, L. M. (2020) · The Ukrainian Biochemical Journal · doi:10.15407/ubj92.04.077 · Cited by 3
Zhang, L., Fan, Z., Li, L., & Sun, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38381 · Cited by 2
Li, X., Wang, X., Zhu, S., Sun, F., Fu, Y., Ban, R., Tan, H. L. E., Yin, Z., Gao, Z., Xu, Z., et al. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103773 · Cited by 2
Yang, X., Liu, M., Shi, H., Hu, M., Lü, Y., Chang, X., & Huang, K. (2025) · Journal of Asthma and Allergy · doi:10.2147/jaa.s516257 · Cited by 2
Quality of Life in Patients With Type 2 Inflammatory Asthma
Ojanguren, Í., Alobid, I., Rodríguez‐Vázquez, V., Reyes, V., Espinosa, M., Smith, Á. L. D. T., Muerza, I., & de la Fuente, E. G. (2025) · Open Respiratory Archives · doi:10.1016/j.opresp.2025.100461 · Cited by 2
Intestinal Neuroimmunology and Its Implications in Food Allergy
Chen, H., & Yang, J. H. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09090-x · Cited by 2
Busse, W. W., Kraft, M., Domingo, C., Messa, I. D. M., Maselli, D. J., Soler, X., Xia, C., Pandit‐Abid, N., Jacob-Nara, J. A., Sacks, H., et al. (2025) · Journal of Asthma · doi:10.1080/02770903.2025.2494233 · Cited by 2
Amygdalin alleviates atopic dermatitis-like skin inflammation via inhibition of Th2 immune responses
Won, S., Jeong, N., Choi, Y., Jin, M., Park, H.-H., Lee, S., & Kim, S. (2025) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2025.2550702 · Cited by 2
Evaluating stapokibart in the treatment of seasonal allergic rhinitis
Wang, M., Li, J., Zhang, L., & Zhang, Y. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2554562 · Cited by 2
Lai, C. P. T., & Yew, Y. W. (2025) · Dermatitis · doi:10.1177/17103568251367706 · Cited by 3
Lactobacillus crispatus KBL693 alleviates atopic dermatitis symptoms through immune modulation
Song, S., Kim, J.-H., Jang, S. J., Jo, E. J., Lim, S. K., & Ko, G. (2025) · The Journal of Microbiology · doi:10.71150/jm.2509005 · Cited by 2
Yosipovitch, G., Kim, B., Koo, J. Y. M., Chen, Z., Wiggins, S., Zahn, J., Sugerman, P. B., Haddad, E., & Cyr, S. L. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01596-8 · Cited by 2
Boesjes, C. M., van der Gang, L. F., Achten, R., Bakker, D. S., van der Rijst, L. P., Dekkers, C., van Wijk, F., Haeck, I. M., de Bruin-Weller, M. S., & de Graaf, M. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2597850 · Cited by 7
The latest investigational drugs for patients with allergic rhinitis
Fang, D., Zhang, Y., & Zhang, L. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2612328 · Cited by 2
Li, S., Lin, J., Yang, X., Qiu, X., Ruan, D., Li, J., Chen, X., Mo, X., & Ju, Q. (2026) · Journal of Dermatological Treatment · doi:10.1080/09546634.2025.2605426 · Cited by 3
Immune imbalance and autoimmune mechanisms in plasma cell mastitis: current perspectives
Xue, B., Jiang, Y., Yan, L., Liu, X., Li, J., Li, Y., Zhang, B., Wang, Y., & Jia, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1727675 · Cited by 4
Simpson, E. L., Bissonnette, R., Deleuran, M. S., Nakahara, T., Galus, R., de Bruin-Weller, M. S., Coleman, A., Spall, M. V., Chen, Z., Avetisova, E., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-025-03458-3 · Cited by 2
Elias, A., Pennock, J. L., McBain, A. J., Keevill, E.-J., & O’Neill, C. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1711723 · Cited by 4
Dupilumab Beyond the Airway: Decreased Morbidity in a Real‐World Analysis
Anisman, E. J., Short, S. H., Tam, E., Bitner, B. F., Alani, A., Rosen, M. R., Rabinowitz, M., Evertz, D. P., Toskala, E. M., & Nyquist, G. (2026) · International Forum of Allergy & Rhinology · doi:10.1002/alr.70111 · Cited by 2
Decision-Making Factors for Systemic Therapies in Atopic Dermatitis: A Clinical Review
Levine, J. P., Mehta, A., O’Hagan, R., Guttman-Yassky, E., & Lamb, A. J. (2026) · Dermatitis · doi:10.1177/17103568261423754 · Cited by 2
Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification
Dominguez-Lopez, R. M., Aranda, C. J., la Fuente, E. G.-D., Pérez‐García, B., Pérez‐Bootello, J., de Aragón, C. A., González-Cantero, Á., & Berná‐Rico, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052371 · Cited by 2
Incidence of autoimmune diseases in children with atopy treated with dupilumab
Gabryszewski, S. J., Hirabayashi, K., Botdorf, M., Maltenfort, M., Forrest, C. B., Guilbert, T. W., Schutt, M., Morizono, H., Vazquez-Garcia, G. A., Garza‐Mayers, A. C., et al. (2026) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2026.03.010 · Cited by 2
Beck, L. A., Simpson, E. L., Thaçi, D., de Bruin-Weller, M. S., Deleuran, M. S., Kataoka, Y., Blauvelt, A., Wollenberg, A., Eichenfield, L. F., Khokhar, F. A., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03582-8 · Cited by 4
Andrzejczak, K., Sternak, A., Witkowski, W., Flak, A., Maj, J., & Ponikowska, M. (2026) · Cells · doi:10.3390/cells15121130 · Cited by 2
The Cytotoxic Effects Of Vesicular Stomatitis Virus On THP-1 Macrophages
Lucero, E. G. (2018) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · doi:10.71889/5fylantbak.29863085 · Cited by 2
Design and optimisation of a small-molecule TLR2/4 antagonist for anti-tumour therapy
Xu, Q., Tian, L., Chen, H., Kong, J. B., Zhang, L., & Yin, H. H. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00175b · Cited by 2
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
de Bruin-Weller, M. S., Merola, J. F., Hong, C.-H., Serra‐Baldrich, E., Ettler, K., Sierka, D., Delevry, D., Chen, Z. B., & Rossi, A. B. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00621-w · Cited by 2
Sofia, C., Simonetti, J., Boccabella, C., & Bonini, M. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-244503 · Cited by 2
Immune mechanisms of atopic dermatitis and new approaches to targeted biological therapy
Потекаев, Н. Н., Tereshchenko, G. P., Khanferyan, R. A., & Леонидович, С. А. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-3-130-136 · Cited by 2
Shogenova, M. S., Hutueva, S. H., & Shogenova, L. S. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.03.201430 · Cited by 2
Dupilumab Failure in Treating Dermatomyositis-Associated Pruritus
O’Brien, M. A., Hsu, S., Shevchenko, A., & Quartey, A. (2022) · Cureus · doi:10.7759/cureus.28270 · Cited by 2
Murashkin, N. N., Opryatin, L. A., Pavlova, E. S., Epishev, R. V., Materikin, A. I., Ivanov, R. A., Savelova, A. A., & Leonova, M. A. (2023) · Вопросы современной педиатрии · doi:10.15690/vsp.v22i5.2622 · Cited by 2
Elisyutina, O. G., Fedenko, E. S., Smolnikov, E. V., Ignatyeva, O. A., & Khaitov, M. R. (2023) · Russian Journal of Allergy · doi:10.36691/rja16905 · Cited by 2
Effect of Hita Tenryo Water™, a natural mineral water, on allergic symptoms induced by cedar in mice
Hamasaki, T., Teruya, K., & Katakura, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26915 · Cited by 2
Kimito, A., Watanabe, Y., Miyamoto, M., Toutani, M., & Mizobuchi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052689 · Cited by 2
Qiu, W., Meng, J., Su, Z., Xie, W., & Song, G. (2024) · MedComm · doi:10.1002/mco2.700 · Cited by 5
Kong, R., Bai, J., Yao, Q., & Xu, X. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107047 · Cited by 3
Monoclonal Antibody Therapy in Childhood Asthma
Tison, K. L., Patrawala, M., & Blaiss, M. S. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00919-3 · Cited by 2
Therapy and control of bronchial asthma in children and adolescents
Суровенко, Т. Н., & Glushkova, E. F. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-10-101-107 · Cited by 2
Biologics in Treatment for Chronic Rhinosinusitis with Comorbid Asthma
Xu, Y., Bi, M., Tan, K. S., Mi, J., & Hong, H. (2021) · Current Treatment Options in Allergy · doi:10.1007/s40521-021-00282-2 · Cited by 2
Dupilumab in the treatment of moderate-to-severe atopic dermatitis: A focused review
Deif, E., Bali, S., & Rajeev, A. (2021) · Journal of Skin and Sexually Transmitted Diseases · doi:10.25259/jsstd_13_2021 · Cited by 2
Biological drugs in the therapy of atopic dermatitis and bronchial asthma: focus on dupilumab
Reviakina, V. A., Geppe, N. A., Malakhov, A. B., Витальевич, К. О., Astafieva, N. G., Kolosova, N. G., & Malakhova-Kapanadze, M. A. (2021) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2021.2.201053 · Cited by 2
Les anticorps monoclonaux à disposition des allergologues pour traiter l’asthme sévère
Tabardel, M., Clark, E., Demoly, P. M., & Caimmi, D. P. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.02.235 · Cited by 4
The efficacy and safety of immunobiological therapy of atopic dermatitis in children
Анатольевна, Л. И., Glukhova, E. A., & Revyakina, V. A. (2022) · Russian Pediatric Journal · doi:10.46563/1560-9561-2022-25-1-46-51 · Cited by 2
The role of IL-1β in the development of diabetes mellitus
Zaiats, L., Fedorchenko, Y., & Żukow, W. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.05.012 · Cited by 2
Franceschini, L., & Farsi, A. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(22)00177-7 · Cited by 2
Nesterenko, Z., Моисеенкова, Ю. А., Ащепкова, О. М., Журавская, Е. Э., Трухманов, М. С., Саидмурадова, Н., Сеитниязова, Г., Джумаева, Б., & Худойкулов, Н. (2022) · Медицина: теория и практика · doi:10.56871/7775.2022.44.54.005 · Cited by 2
Lehman, H. K., & Sabella, C. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00039-4 · Cited by 2
The Blood Biomarkers of Asthma
Chen, H., Yu-bao, C., & Rongfei, Z. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106807 · Cited by 2
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?
Kourid, M.-I., & Couillard, S. (2025) · European Respiratory Journal · doi:10.1183/13993003.00153-2025 · Cited by 2
The role of atopy patch test with aeroallergens in allergic diseases diagnostics
Smolnikov, E. V., Litovkina, A. O., Kolykhalova, K. I., Elisyutina, O. G., & Fedenko, E. S. (2021) · Russian Journal of Allergy · doi:10.36691/rja1355 · Cited by 1
The Simultaneous Inhibition of IL‑4 and IL‑13 by Dupilumab
Sanchez, A. P. G., & Fernandes, T. E. A. (2021) · Journal of Clinical Research in Dermatology · doi:10.15226/2378-1726/8/2/001138 · Cited by 1
Wang, X., Wu, D., Duan, T., Liu, Y., Lv, S., Cui, L., Ding, C., & Xu, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2101 · Cited by 1
Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases
Humphry, N. (2019) · EMJ Dermatology · doi:10.33590/emjdermatol/10314590 · Cited by 1
Díez-González, L., Martín-Villares, C., Martín-Sigüenza, G., & Álvarez-Álvarez, I. (2023) · Revista ORL · doi:10.14201/orl.31186 · Cited by 1
Biologic Therapies: Targeting Severe Asthma at the Molecular Level
Szewczyk, K., Szewczyk, B., Krzesłowska, W. J., Pytel, P., Wiśniewski, S., & Hołownia, W. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.74.52570 · Cited by 1
Joshi, H., & Shah, B. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00475 · Cited by 1
Science, I. M. A. (2024) · EMJ Respiratory · doi:10.33590/emjrespir/ikhc2212 · Cited by 1
Сергеевич, К. Г., Валентиновна, К. И., Ryabichenko, T. I., Обухова, О. О., & Voevoda, M. I. (2024) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2024-23-4-29-34 · Cited by 1
Hu, C., Li, J., Yuan, Y., & Jin, R. (2025) · PubMed · doi:10.7499/j.issn.1008-8830.2408143 · Cited by 2
Wang, Y., Yin, H., Li, Z., Wu, H., Wang, Q., Chen, X., Mao, L., Wu, Y., Wang, S., Qin, H., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.02.145 · Cited by 1
Bei, Y., Teng, S., & Zhan, L. (2025) · Clinical Pediatrics · doi:10.1177/00099228251321597 · Cited by 1
Li, B., Yao, W., Diao, R., Yang, B., Wang, Y., Li, T., Ge, L., & Wang, H. (2025) · International Medical Case Reports Journal · doi:10.2147/imcrj.s514339 · Cited by 3
Shams, R. B., Patel, H. S., & Sayed, C. J. (2025) · Allergies · doi:10.3390/allergies5020020 · Cited by 1
Metadata
- Authors
- Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D.
- Affiliations
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Corresponding author
- Gandhi, Namita A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-16
- Volume
- 15
- Issue
- 1
- Pages
- 35-50
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2200308911
- Cited by
- 766
- References
- 156
- Citations by year
- 2026: 70 · 2025: 104 · 2024: 113 · 2023: 77 · 2022: 106 · 2021: 99 · 2020: 63 · 2019: 43 · 2018: 33 · 2017: 38 · 2016: 18
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Regeneron Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- type 2 inflammation, IL-4, IL-5, IL-13, asthma, atopic dermatitis, Th2 cells, allergic diseases, IL-4 receptor alpha inhibition, IL-13 inhibition, IL-5 inhibition, personalized asthma therapy, drug candidates
- MeSH terms
- Antibodies, Monoclonal, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Interleukin-4, Interleukin-5, Models, Immunological, Interleukin-13, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.